Table 2 Summary and distribution of fibrosis results according to group

Valid Fibroscan

36/40 (90%)

38/41 (93%)

32/37 (86%)

29/30 (97%)

Fibroscan (kPa)

n = 36

n = 38

n = 32

n = 29

< 7.0

21 (58%)

19 (50%)

28 (88%)

23 (79%)

7.0–13

11 (31%)

12 (32%)

1 (3%)

6 (21%)

≥13

4 (11%)

7 (18%)

3 (9%)

–

APRI

n = 43

n = 35

n = 26

n = 22

< 0.5

31 (72%)

25 (71%)

21 (81%)

19 (86%)

0.5–1.5

9 (21%)

7 (20%)

4 (15%)

3 (14%)

> 1.5

3 (7%)

3 (9%)

1 (4%)

–

FIB-4

n = 42

n = 34

n = 26

n = 22

< 1.30

31 (74%)

27 (79%)

19 (73%)

20 (91%)

1.30–3.25

9 (21%)

4 (12%)

7 (27%)

2 (9%)

> 3.25

2 (5%)

3 (9%)

–

–

ALT, U/L^a

34 (24–45)

25 (22–47)

31 (21–44)

24 (19–39)

AST, U/L^a

31 (25–46)

27 (23–42)

32 (27–45)

21 (18–32)

Fibroscan, kPa^a

6.2 (4.8–8.0)

6.9 (5.5–8.8)

4.7 (3.9–5.9)

5.6 (4.6–6.8)

APRI^a

0.32 (0.24–0.58)

0.34 (0.21–0.66)

0.32 (0.23–0.46)

0.21 (0.13–0.42)

FIB-4^a

0.96 (0.58–1.30)

0.86 (0.59–1.20)

0.77 (0.55–1.30)

0.63 (0.41–1.00)